FdaApplication
NDA 020937
Identifiers
- fda_app_no: NDA020937
Properties
| Property | Value |
|---|---|
| applicant_name | LIEBEL-FLARSHEIM CO LLC |
| application_type | NDA |
| approval_date | 1999-12-08 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPTIMARK | GADOVERSETAMIDE | 3309MG/10ML (330.9MG/ML) | INJECTABLE;INJECTION |
| OPTIMARK | GADOVERSETAMIDE | 1654.5MG/5ML (330.9MG/ML) | INJECTABLE;INJECTION |
| OPTIMARK | GADOVERSETAMIDE | 4963.5MG/15ML (330.9MG/ML) | INJECTABLE;INJECTION |
| OPTIMARK | GADOVERSETAMIDE | 6618MG/20ML (330.9MG/ML) | INJECTABLE;INJECTION |
4 products